Citation: | CHEN Shaobo, LIU Weinan, ZHANG Shengjie, SUN Jian, YANG Rui, WANG Shujun, CHEN Ge. Clinical Efficacy, Safety and Pharmacokinetics of Tracing Injection of Mitoxantrone Hydrochloride for Tracing Sentinel Lymph Nodes in Thyroid Carcinoma: A Phase Ⅰ Clinical Trial[J]. JOURNAL OF MECHANICAL ENGINEERING, 2021, 12(5): 729-735. doi: 10.12290/xhyxzz.2021-0281 |
[1] |
杨雷, 王宁. 甲状腺癌流行病学研究进展[J]. 中华预防医学杂志, 2014, 48: 744-748. doi: 10.3760/cma.j.issn.0253-9624.2014.08.021
Yang L, Wang N. Progress in epidemiological study of thyroid cancer[J]. Zhonghua Yufang Yixue Zazhi, 2014, 48: 744-748. doi: 10.3760/cma.j.issn.0253-9624.2014.08.021
|
[2] |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41: 19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005
Zheng RS, Sun KX, Zhang SW, et al. Report of cancer epidemiology in China, 2015[J]. Zhonghua Zhongliu Zazhi, 2019, 41: 19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005
|
[3] |
赫捷. 肿瘤学概论[M]. 北京: 人民卫生出版社, 2018: 52.
|
[4] |
马倩君, 吴干勋, 赵瑞力, 等. 淋巴示踪剂在甲状腺癌中央区清扫中的研究进展[J]. 中国医学文摘(耳鼻咽喉科学), 2019, 34: 283-287. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYEB201904014.htm
Ma QJ, Wu GX, Zhao RL, et al. Progress in the study of lymphatic tracer in central lymph dissection of thyroid carcinoma[J]. Zhongguo Yixue Wenzhai(Erbiyanhou Kexue), 2019, 34: 283-287. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYEB201904014.htm
|
[5] |
杨瑞, 王淑君, 张颖. 亚甲蓝作为淋巴示踪剂的研究与展望[J]. 中国药剂学杂志, 2009, 7: 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-PZGY200902006.htm
Yang R, Wang SJ, Zhang Y. Research and Prospect of Methylene Blue as Lymphatic Tracer[J]. Zhongguo Yaojixue Zazhi, 2009, 7: 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-PZGY200902006.htm
|
[6] |
Maniakas A, Forest VI, Jozaghi Y, et al. Tumor classifica-tion in well-differentiated thyroid carcinoma and sentinel lymph node biopsy outcomes: a direct correlation[J]. Thyroid, 2014, 24: 671-674. doi: 10.1089/thy.2013.0160
|
[7] |
李理, 王瑶琪, 孟宪瑛, 等. 纳米碳标记的淋巴导向示踪技术在甲状腺全切术中应用的研究进展[J]. 吉林大学学报(医学版), 2015, 41: 1095-1098. https://www.cnki.com.cn/Article/CJFDTOTAL-BQEB201505043.htm
Li L, Wang YQ, Meng XY, et al. Progress research on application of lymphatic tracer marked by carbon nanoparticles in total thyroidectomy[J]. Jilin Daxue Xuebao (Yixueban), 2015, 41: 1095-1098. https://www.cnki.com.cn/Article/CJFDTOTAL-BQEB201505043.htm
|
[8] |
中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识[J]. 中国实用外科杂志, 2015, 35: 731-736. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201507013.htm
Thyroid Surgeon Committee of Chinese College of Surgeons. Expert consensus on parathyroid gland protection in thyroid surgery[J]. Zhongguo Shiyong Waike Zazhi, 2015, 35: 731-736. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201507013.htm
|
[9] |
宋洪明. 前哨淋巴结活检在甲状腺癌中的应用[J]. 同济大学学报(医学版), 2015, 36: 119-123. https://www.cnki.com.cn/Article/CJFDTOTAL-TJIY201504026.htm
Song HM. Application of sentinel lymph node biopsy in thyroid cancer management[J]. Tongji Daxue Xuebao (Yixueban), 2015, 36: 119-123. https://www.cnki.com.cn/Article/CJFDTOTAL-TJIY201504026.htm
|
[10] |
吴耀华. 淋巴示踪技术在甲状腺癌手术中的应用[J]. 临床外科杂志, 2017, 25: 832-834. doi: 10.3969/j.issn.1005-6483.2017.11.010
Wu YH. Application of lymphatic tracing technique in thyroid cancer surgery[J]. Linchuang Waike Zazhi, 2017, 25: 832-834. doi: 10.3969/j.issn.1005-6483.2017.11.010
|
[11] |
Mao YL, Liu J, Shi TY, et al. A Novel Self-Assembly Nanocrystal as Lymph Node-Targeting Delivery System: Higher Activity of Lymph Node Targeting and Longer Efficacy Against Lymphatic Metastasis[J]. AAPS Pharm Sci Tech, 2019, 20: 292. doi: 10.1208/s12249-019-1447-3
|
[12] |
Larson RA, Daly KM, Choi KE, et al. A Clinical and Pharmacokinetic Study of Mitoxantrone in Acute Nonlymphocytic Leukemia[J]. J Clin Oncol, 1987, 5: 391-397. doi: 10.1200/JCO.1987.5.3.391
|
[13] |
Stiff PJ, McKenzie RS, Alberts DS, et al. Phase Ⅰ Clinical and Pharmacokinetic Study of High-Dose Mitoxantrone Combined With Carboplatin, Cyclophosphamide, and Autologous Bone Marrow Rescue: High Response Rate for Refractory Ovarian Carcinoma[J]. J Clin Oncol, 1994, 12: 176-183. doi: 10.1200/JCO.1994.12.1.176
|